Personalis
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Personalis and other ETFs, options, and stocks.About PSNL
Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives.
PSNL Key Statistics
Stock Snapshot
With a market cap of 1.23B, Personalis(PSNL) trades at $11.85. The stock has a price-to-earnings ratio of -11.58.
On 2026-07-25, Personalis(PSNL) stock moved within a range of $11.74 to $12.63. With shares now at $11.85, the stock is trading +1.0% above its intraday low and -6.2% below the session's peak.
Trading activity shows a volume of 2.9M, compared to an average daily volume of 6.83M.
The stock's 52-week range extends from a low of $3.84 to a high of $16.39.
The stock's 52-week range extends from a low of $3.84 to a high of $16.39.
PSNL News
Tempus AI has agreed to acquire Personalis (NasdaqGM:PSNL) in a definitive transaction. Following the deal announcement, Monteverde & Associates launched an in...
...
Tempus AI shares erased early losses and recovered after an initial selloff tied to the company’s acquisition of Personalis. Tempus AI Targets $20 Billion MRD...
Analyst ratings
50%
of 6 ratingsMore PSNL News
BTIG raised the firm’s price target on Personalis (PSNL) to $16.25 from $11 and keeps a Buy rating on the shares after Tempus AI (TEM) said it will acquire Pers...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Morgan Stanley notes that Tempus AI (TEM) announced a definitive agreement to acquire Personalis (PSNL) for $16.25 per share, with the deal expected to close in...
Catch up on the top artificial intelligence news and commentary by Wall Street analysts on publicly traded companies in the space with this daily recap compiled...
This acquisition, valued at $1.5 billion, is set to expand Tempus’ reach in the MRD market. Tempus claims it presents a $20 billion opportunity. Key Deal Terms...
08:31 EDT Tempus AI (TEM) to acquire Personalis (PSNL) for $16.25 per share Published first on TheFly – the ultimate source for real-time, market-moving breaki...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.